key: cord-0901372-83w86me6
authors: Mohamedbhai, H.; Visavadia, B.
title: P2 Surgery: Crisis…what crisis?
date: 2021-05-14
journal: Br Dent J
DOI: 10.1038/s41415-021-3029-5
sha: ea0bd4b721e35c34bf8010ed9ec149f288bdbd32
doc_id: 901372
cord_uid: 83w86me6

nan

https://doi.org/10.1038/s41415-021-3029-5 I therefore approached the Infection Prevention and Control (IPC) lead in my employing trust to seek approval for the introduction of these masks in to our CDS. I was somewhat surprised by the response which effectively actively discouraged their use. The IPC view was that 'despite claims from manufacturers, these masks have not been designed for use in healthcare. As such their ability to be easily decontaminated has not been thought out with IPC in mind. The materials or fabrics used and the complex design conflicts with decontamination'.

This response presented a dilemma. Either the reusable masks are a suitable product, in which case they should be available to all dentists and DCPs, irrespective of branch of dentistry, or the limitations should be clearly set out and their use either prohibited or restricted to very specific circumstances. I was pleased to receive the NHS Dentistry and Oral Health Update dated 25 February 2021 (NHS England) with details of a new service to deal with PPE-related complaints and enquiries (ppe.complaintsandenquiries@ nhs.net). Contact with them provided a prompt response containing the following link with relevant, important information: http://www.medidex.com/research/866reprocessing-of-respirator-masks-covid19. html, leading to the UK Decision Making Committee on PPE (DMC) interim advice paper. 1 3 However, this national strategy has been implemented at a local level, where there are substantial differences from region to region. This variation has not aligned with either cancer or COVID-19 demand. Instead, this has been due to the ability to escalate beds and surgical capacity. 4 The main increases in capacity have been the independent sector and the creation of cancer hubs. Some regions have more private hospitals, so finding additional operative capacity is relatively easier. 5 The development of cancer hubs has helped some regions, but not equitably. For instance, the North West region has seen a 188% increase in their 104 day breaches versus London at 98%. 1 Between specialities, there exists a large difference in activity too, with head and neck cancer (HNC) being one of the greatest affected. Dentists, the largest referral base for HNC, have seen a reduction in activity to 25%, compared to 2019 resulting in a 55% decrease in such referrals in April 2020 compared to 33% for lower GI malignancies. 6 Whilst the strategy for priority triaging of patients has been well intended and needed, it has failed to take into account regional variations of services and different specialities. 

Elective surgery cancellations due to COVID-10 pandemic: global predictive modelling to inform surgical recovery plans

Mortality due to cancer treatment delay: systematic review and meta-analysis

Exclusive: Give urgent cancer surgery the same priority as covid patients, NHS England tells service

UK Head and neck cancer surgical capacity during the second wave of the COVID-19 pandemic: Have we learned the lessons? COVIDSurg collaborative

Systemic Anti-Cancer Therapy COVID-19 Dashboard

The disruption and recovery of cancer from COVID-19: pathway, outcomes and restarting. Carnall Farrar